Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
HARVEY PARTNERS, LLC | 2,911,500 7.000% |
2,911,500 (New Position) |
Filing History |
| 2023-02-13 5:12 pm Purchase |
2022-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
Punch & Associates Investment Management, Inc. | 2,764,039 6.640% |
597,264 (+27.56%) |
Filing History |
| 2023-02-13 3:55 pm Sale |
2022-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
Portolan Capital Management, LLC | 1,054,300 2.530% |
-1,484,499 (-58.47%) |
Filing History |
| 2023-01-11 1:30 pm Sale |
2023-01-06 | 13G | Harvard Bioscience, Inc. HBIO |
Leviticus Partners LP | 2,053,907 4.930% |
-200,000 (-8.87%) |
Filing History |
| 2022-12-21 4:20 pm Purchase |
2022-12-16 | 13G | Harvard Bioscience, Inc. HBIO |
Leviticus Partners LP | 2,253,907 5.410% |
2,253,907 (New Position) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Harvard Bioscience, Inc. HBIO |
BlackRock Inc. BLK |
1,209,119 2.900% |
-1,854,071 (-60.53%) |
Filing History |
| 2022-06-21 4:01 pm Purchase |
2022-06-10 | 13G | HARVARD APPARATUS REGENERATIVE HRGN |
HARVARD BIOSCIENCE INC HBIO |
708,516 5.800% |
708,516 (New Position) |
Filing History |
| 2022-02-14 11:02 am Purchase |
2021-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
Punch & Associates Investment Management, Inc. | 2,166,775 5.310% |
2,166,775 (New Position) |
Filing History |
| 2022-02-11 2:01 pm Purchase |
2021-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
Portolan Capital Management, LLC | 2,538,799 6.220% |
473,154 (+22.91%) |
Filing History |
| 2022-02-08 3:52 pm Sale |
2022-02-14 | 13G | Harvard Bioscience, Inc. HBIO |
DIMENSIONAL FUND ADVISORS LP | 1,883,598 4.600% |
-143,393 (-7.07%) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
BlackRock Inc. BLK |
3,063,190 7.500% |
109,285 (+3.70%) |
Filing History |
| 2021-09-03 2:37 pm Purchase |
2021-08-24 | 13G | Harvard Bioscience, Inc. HBIO |
Portolan Capital Management, LLC | 2,065,645 5.070% |
2,065,645 (New Position) |
Filing History |
| 2021-02-16 3:14 pm Sale |
2020-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
Potomac Capital Management Inc. | 4,500 0.010% |
-2,082,901 (-99.78%) |
Filing History |
| 2021-02-12 5:13 pm Sale |
2021-02-16 | 13G | Harvard Bioscience, Inc. HBIO |
DIMENSIONAL FUND ADVISORS LP | 2,026,991 5.200% |
-105,805 (-4.96%) |
Filing History |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
BlackRock Inc. BLK |
2,953,905 7.600% |
1,505,228 (+103.90%) |
Filing History |
| 2020-06-22 12:40 pm Sale |
2020-06-19 | 13D | Harvard Bioscience, Inc. HBIO |
ENGINE CAPITAL L.P. | 1,877,121 4.900% |
-883,478 (-32.00%) |
Filing History |